Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:TMDI Titan Medical (TMDI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Titan Medical Stock (NASDAQ:TMDI) 30 days 90 days 365 days Advanced Chart Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get Titan Medical alerts:Sign Up Key Stats Today's Range$0.13▼$0.1550-Day Range$0.13▼$0.8952-Week Range$0.13▼$1.20Volume7.71 million shsAverage Volume4.83 million shsMarket Capitalization$15.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewTitan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.Read More… JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Receive TMDI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Titan Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address TMDI Stock News HeadlinesConavi Medical Corp. Commences Trading on TSX-V Under Symbol “CNVI”October 18, 2024 | markets.businessinsider.comTitan Submersible HearingsSeptember 25, 2024 | msn.comTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.November 21, 2024 | Angel Publishing (Ad)Medi Assist, Tata Elxsi, Tata Tech, ABB India Gain While Titan, Minda Corp, Syngene Slump In tradeAugust 27, 2024 | msn.comTitan Enterprises Releases New Display Model of its Popular Pulsite® Link Flow InstrumentAugust 16, 2024 | msn.comTitan Medical Inc.: Titan Medical Reports Operating and Financial Results for the Second Quarter 2024August 16, 2024 | finanznachrichten.deTitan Medical Inc.: Titan Medical Reports Financial Results for the First Quarter 2024May 13, 2024 | finanznachrichten.deTMD:CA Titan Medical Inc.April 21, 2024 | seekingalpha.comSee More Headlines TMDI Stock Analysis - Frequently Asked Questions How were Titan Medical's earnings last quarter? Titan Medical Inc. (NASDAQ:TMDI) announced its earnings results on Thursday, November, 11th. The company reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by $0.02. What other stocks do shareholders of Titan Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Titan Medical investors own include NIO (NIO), Tesla (TSLA), Advanced Micro Devices (AMD), FuelCell Energy (FCEL), Micron Technology (MU), Plug Power (PLUG) and Sorrento Therapeutics (SRNE). Company Calendar Last Earnings11/11/2021Today11/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:TMDI CUSIPN/A CIK840551 Webwww.titanmedicalinc.com Phone(416) 548-7522FaxN/AEmployees49Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,860,000.00 Net MarginsN/A Pretax Margin-209.87% Return on Equity-167.03% Return on Assets-112.15% Debt Debt-to-Equity RatioN/A Current Ratio1.41 Quick Ratio1.41 Sales & Book Value Annual Sales$20.09 million Price / Sales0.78 Cash FlowN/A Price / Cash FlowN/A Book Value$0.32 per share Price / Book0.44Miscellaneous Outstanding Shares111,950,000Free Float111,932,000Market Cap$15.67 million OptionableNot Optionable Beta2.36 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (NASDAQ:TMDI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
